301 related articles for article (PubMed ID: 27865639)
1. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions.
Antonopoulos CN; Mylonas SN; Moulakakis KG; Sergentanis TN; Sfyroeras GS; Lazaris AM; Kakisis JD; Vasdekis SN
J Vasc Surg; 2017 Jan; 65(1):234-245.e11. PubMed ID: 27865639
[TBL] [Abstract][Full Text] [Related]
2. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
[No Abstract] [Full Text] [Related]
3. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787
[TBL] [Abstract][Full Text] [Related]
4. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
5. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
Kawamura Y; Ishii H; Aoyama T; Tanaka M; Takahashi H; Kumada Y; Toriyama T; Murohara T
J Vasc Surg; 2009 Nov; 50(5):1057-62. PubMed ID: 19782527
[TBL] [Abstract][Full Text] [Related]
6. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial.
Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP
Trials; 2013 Mar; 14():87. PubMed ID: 23537403
[TBL] [Abstract][Full Text] [Related]
8. Evolving modalities for femoropopliteal interventions.
Ansel GM; Lumsden AB
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
[TBL] [Abstract][Full Text] [Related]
9. New stents for SFA.
MINAR E; SCHILLINGER M
J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials.
Zhou Y; Wang T; He H; Li Q; Wan Z; Lu P; Shu C
Int J Cardiol; 2024 Jun; 404():131977. PubMed ID: 38508322
[TBL] [Abstract][Full Text] [Related]
11. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
Acin F; de Haro J; Bleda S; Varela C; Esparza L
J Endovasc Ther; 2012 Oct; 19(5):585-95. PubMed ID: 23046322
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
[TBL] [Abstract][Full Text] [Related]
13. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
[TBL] [Abstract][Full Text] [Related]
14. Comparative Efficacy and Safety of Endovascular Treatment Modalities for Femoropopliteal Artery Lesions: A Network Meta-analysis of Randomized Controlled Trials.
Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
Cardiovasc Intervent Radiol; 2020 Feb; 43(2):204-214. PubMed ID: 31646376
[TBL] [Abstract][Full Text] [Related]
15. Midterm Patency After Femoropopliteal Interventions: A Comparison of Standard and Interwoven Nitinol Stents and Drug-Coated Balloons in a Single-Center, Propensity Score-Matched Analysis.
Steiner S; Schmidt A; Bausback Y; Piorkowski M; Werner M; Yahiaoui-Doktor M; Banning-Eichenseer U; Scheinert D
J Endovasc Ther; 2016 Apr; 23(2):347-55. PubMed ID: 26848131
[TBL] [Abstract][Full Text] [Related]
16. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.
Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954
[TBL] [Abstract][Full Text] [Related]
17. Primary stenting of the superficial femoral and popliteal artery.
Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
[TBL] [Abstract][Full Text] [Related]
18. Primary nitinol stenting for femoropopliteal disease.
Mewissen MW
J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
[TBL] [Abstract][Full Text] [Related]
19. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
[TBL] [Abstract][Full Text] [Related]
20. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
